看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
0 u2 q1 `& U \3 f t! C3 H
8 ^' [7 V( P. ]$ P2 ?$ @& ]% ]: }! A" A' q3 }0 O6 K
Currently available feasibility data for possible combination strategies. 0 \& q( K" M% S ^
————————————————————————————————
5 d4 B2 K7 `8 l6 q( m# ACombination Feasibility according to preliminary data
* I# `3 w" r. `1 ^——————————————————————————————————
8 e$ [8 u* C* N/ b* jBevacizumab + sorafenib Yes, reduced dose 4 i, y$ E7 h8 r( q' @& s2 R S
Bevacizumab + sunitinib† No 1 p3 s/ z: \ d+ {
Bevacizumab + temsirolimus Yes
- h6 i$ Z+ h3 l: TBevacizumab + everolimus Yes
+ y# v: w+ d" k H4 K8 ]Sorafenib + sunitinib ?
, F( O! N3 ~2 q1 x& s! l4 ?% U" ]Sorafenib + temsirolimus Yes, reduced dose 3 L) `% o8 ]1 X
Sorafenib + everolimus Yes, reduced dose $ ?% j, G2 y! q3 z* Y5 C" k
Sunitinib + temsirolimus† No * e5 T3 p% u4 `. I
Sunitinib + everolimus ?
# m( t X4 r3 b4 ~$ o9 yTemsirolimus + everolimus ?
& w/ D* n# h) M————————————————————: }% A# c/ v( k2 k% X \
†Led to US FDA warning.. @# }; b: D8 \8 R8 B5 u" F" e
?: As yet unattempted combination.
: x! C" }7 }$ ` C4 q5 n E |